AbbVie (NYSE: ABBV)
AbbVie Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
AbbVie Company Info
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
News & Analysis
The Smartest Dividend Stocks to Buy With $500 Right Now
Some prominent healthcare and consumer stocks have fallen out of favor with the market, so now is the time to pounce on some great deals.
2 No-Brainer Dividend Stocks to Buy With $250 in 2025
20 High-Yield Dividend Stocks to Buy in 2024
A list of high-yielding dividend stocks to consider buying now.
What Are Blue Chip Stocks? Should I Invest in Them?
Is AbbVie Stock a Buy?
2 Excellent Dividend Stocks to Buy on the Dip
2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
3 Fantastic Stocks That Could Enjoy a Santa Claus Rally
Valuation
Earnings Transcripts
AbbVie (ABBV) Q3 2024 Earnings Call Transcript
ABBV earnings call for the period ending September 30, 2024.
AbbVie (ABBV) Q2 2024 Earnings Call Transcript
ABBV earnings call for the period ending June 30, 2024.
AbbVie (ABBV) Q1 2024 Earnings Call Transcript
ABBV earnings call for the period ending March 31, 2024.
AbbVie (ABBV) Q4 2023 Earnings Call Transcript
ABBV earnings call for the period ending December 31, 2023.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.